Page last updated: 2024-08-25

methotrexate and Fallopian Tube Diseases

methotrexate has been researched along with Fallopian Tube Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.67)18.7374
1990's4 (26.67)18.2507
2000's6 (40.00)29.6817
2010's3 (20.00)24.3611
2020's1 (6.67)2.80

Authors

AuthorsStudies
Copel, L; Dvash, S; Gat, I; Maymon, R; Melcer, Y; Pekar-Zlotin, M; Youngster, M1
Sargin, MA; Tug, N; Yassa, M1
Gay, C; Laroche, J; Malincenco, M; Mottet, N; Riethmuller, D; Royer, PY1
Al Sayed, I1
Buster, JE; Carson, SA; Dudley, PS; Heard, MJ; Sangi-Haghpeykar, H1
Camano, L; Elito, J; Han, KK1
Camano, L; Elito Junior, J; Han, KK1
Harding, A; O'Shea, RT; Thompson, GR1
Bohrer, MK; Corsan, GH; Karacan, M; Kemmann, E; Qasim, S; Ransom, MX1
De Stefano, R; Di Carlo, C; Mastrantonio, P; Nappi, C; Pellicano, M; Zullo, F1
Brown, TL; Green, BA; Horan, CA; Maher, JE; Ripps, BA; Tolaymat, LL1
Hanzal, E; Klem, I; Kölbl, H; Kucera, E; Leodolter, S; Sam, C; Schindl, M; Sliutz, G1
Sammour, A; Tulandi, T1
Cosson, M; Ego, A; Houfflin-Debarge, V; Legoueff, F; Querleu, D; Subtil, D1
Buster, JE; Ling, FW; Stovall, TG1

Reviews

1 review(s) available for methotrexate and Fallopian Tube Diseases

ArticleYear
Evidence-based management of ectopic pregnancy.
    Current opinion in obstetrics & gynecology, 2000, Volume: 12, Issue:4

    Topics: Fallopian Tube Diseases; Female; Humans; Laparoscopy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Risk Factors; Rupture, Spontaneous

2000

Trials

1 trial(s) available for methotrexate and Fallopian Tube Diseases

ArticleYear
Intra-amniotic methotrexate versus CO2 laser laparoscopic salpingotomy in the management of tubal ectopic pregnancy--a prospective randomized trial.
    Fertility and sterility, 1994, Volume: 62, Issue:4

    Topics: Adult; Amnion; Carbon Dioxide; Chorionic Gonadotropin; Fallopian Tube Diseases; Female; Humans; Injections; Laparoscopy; Laser Therapy; Methotrexate; Pregnancy; Pregnancy, Ectopic; Prospective Studies; Salpingostomy; Treatment Failure

1994

Other Studies

13 other study(ies) available for methotrexate and Fallopian Tube Diseases

ArticleYear
Tubal patency assessment using sequential transvaginal ultrasound and hysterosalpingo-foam sonography after methotrexate treatment for tubal pregnancy.
    Reproductive biomedicine online, 2022, Volume: 44, Issue:2

    Topics: Fallopian Tube Diseases; Fallopian Tubes; Female; Humans; Male; Methotrexate; Pregnancy; Pregnancy, Tubal; Prospective Studies

2022
Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
    Gynecologic and obstetric investigation, 2019, Volume: 84, Issue:1

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tube Diseases; Female; Humans; Methotrexate; Middle Aged; Pregnancy; Pregnancy, Tubal; Retrospective Studies; Rupture, Spontaneous; Treatment Failure; Young Adult

2019
[Successive ectopic pregnancies associated with tubal shistosomiasis in a French traveler].
    The Pan African medical journal, 2016, Volume: 23

    Topics: Adult; Fallopian Tube Diseases; Female; Humans; Mali; Methotrexate; Pregnancy; Pregnancy, Ectopic; Salpingectomy; Schistosomiasis haematobia; Travel

2016
Assessment of β-human chorionic gonadotropin level as a reliable predictor of tubal patency confirmed with transvaginal ultrasound-guided selective salpingography (TVSSG) following conservative treatment of tubal pregnancy.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tube Diseases; Fallopian Tubes; Female; Humans; Hysterosalpingography; Injections, Intramuscular; Methotrexate; Predictive Value of Tests; Pregnancy; Pregnancy, Tubal; Prognosis; Prospective Studies; Ultrasonography; Young Adult

2012
Characterizing ectopic pregnancies that rupture despite treatment with methotrexate.
    Fertility and sterility, 2004, Volume: 82, Issue:5

    Topics: Abortifacient Agents, Nonsteroidal; Case-Control Studies; Chorionic Gonadotropin; Fallopian Tube Diseases; Female; Humans; Methotrexate; Predictive Value of Tests; Pregnancy; Pregnancy, Ectopic; Retrospective Studies; Risk Factors; Rupture, Spontaneous

2004
Values of beta-human chorionic gonadotropin as a risk factor for tubal obstruction after tubal pregnancy.
    Acta obstetricia et gynecologica Scandinavica, 2005, Volume: 84, Issue:9

    Topics: Abortifacient Agents, Nonsteroidal; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tube Diseases; Female; Humans; Hysterosalpingography; Immunoenzyme Techniques; Logistic Models; Methotrexate; Pregnancy; Pregnancy, Tubal; Prospective Studies; Risk Factors; Ultrasonography, Doppler, Color

2005
Tubal patency following surgical and clinical treatment of ectopic pregnancy.
    Sao Paulo medical journal = Revista paulista de medicina, 2006, Sep-07, Volume: 124, Issue:5

    Topics: Abortifacient Agents, Nonsteroidal; Chi-Square Distribution; Fallopian Tube Diseases; Fallopian Tube Patency Tests; Fallopian Tubes; Female; Humans; Hysterosalpingography; Infertility, Female; Methotrexate; Postoperative Period; Pregnancy; Pregnancy, Ectopic; Prospective Studies; Salpingostomy; Time Factors

2006
Identification of hormonal parameters for successful systemic single-dose methotrexate therapy in ectopic pregnancy.
    Human reproduction (Oxford, England), 1995, Volume: 10, Issue:10

    Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Embryo Transfer; Fallopian Tube Diseases; Female; Humans; Methotrexate; Ovulation Induction; Pregnancy; Pregnancy, Ectopic; Progesterone; Rupture, Spontaneous

1995
Late complications after systemic methotrexate treatment of unruptured ectopic pregnancies: a report of three cases.
    European journal of obstetrics, gynecology, and reproductive biology, 1996, Dec-27, Volume: 70, Issue:2

    Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tube Diseases; Female; Hematocele; Hemorrhage; Humans; Male; Methotrexate; Pelvis; Pregnancy; Pregnancy, Ectopic; Ultrasonography

1996
Reproductive potential after methotrexate treatment of ectopic gestation in a community hospital.
    The Journal of reproductive medicine, 1999, Volume: 44, Issue:4

    Topics: Abortifacient Agents, Nonsteroidal; Fallopian Tube Diseases; Fallopian Tube Patency Tests; Female; Fluoroscopy; Hospitals, Community; Humans; Hysterosalpingography; Methotrexate; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Retrospective Studies; Salpingostomy; Treatment Outcome

1999
Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?
    Gynecologic and obstetric investigation, 2000, Volume: 49, Issue:1

    Topics: Adult; Chorionic Gonadotropin, beta Subunit, Human; Fallopian Tube Diseases; Female; Humans; Methotrexate; Pregnancy; Pregnancy, Ectopic; Rupture, Spontaneous; Ultrasonography

2000
Survival analysis of fertility after ectopic pregnancy.
    Fertility and sterility, 2001, Volume: 75, Issue:3

    Topics: Adult; Ethnicity; Fallopian Tube Diseases; Female; Follow-Up Studies; France; Humans; Infertility, Female; Intrauterine Devices, Copper; Logistic Models; Methotrexate; Odds Ratio; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Prospective Studies; Risk Factors; Rupture, Spontaneous; Smoking

2001
Outpatient chemotherapy of unruptured ectopic pregnancy.
    Fertility and sterility, 1989, Volume: 51, Issue:3

    Topics: Adult; Ambulatory Care; Aspartate Aminotransferases; Chorionic Gonadotropin; Drug Administration Schedule; Drug Therapy, Combination; Fallopian Tube Diseases; Female; Humans; Leucovorin; Methotrexate; Pregnancy; Pregnancy, Ectopic; Prospective Studies; Rupture, Spontaneous

1989